Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03442270 · ClinicalTrials.gov registry record
Detection Rate of Serrated Adenomas in Screening Colonoscopy
A clinical trial of Healthy Patients Undergoing Screening Colonoscopy, sponsored by TriHealth.
- Completed
- Registry status
- 276
- Enrollment target
- 1
- Study location
NCT03442270 is a study of Healthy Patients Undergoing Screening Colonoscopy that has completed, run by TriHealth. The registered enrollment target is 276 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03442270, a study of Healthy Patients Undergoing Screening Colonoscopy, has completed, sponsored by TriHealth.
- COMPLETED
- Registry status
- 276 participants
- Enrollment target
- 1
- Study location
Study Summary
An observational prospective will be conducted to determine the detection rate of serrated adenoma during screening colonoscopy at our institution. Additionally, the variability of serrated adenoma detection among endoscopists will be evaluated and the characteristics of serrated adenomas will be described.
Conditions Studied
Interventions
- OTHER No Intervention
Study Locations (1)
Ohio
- Good Samaritan Hospital - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 276 participants |
| Start Date | 2018-03-20 |
| Est. Completion | 2018-11-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03442270
The ClinicalTrials.gov registry entry for NCT03442270 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 276 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is TriHealth, which has 81 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Healthy Patients Undergoing Screening Colonoscopy appearing as the primary indexed condition, and to 1 intervention - of which No Intervention is the first listed.
NCT03442270 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT03442270 about?
NCT03442270 is a clinical study titled "Detection Rate of Serrated Adenomas in Screening Colonoscopy". An observational prospective will be conducted to determine the detection rate of serrated adenoma during screening colonoscopy at our institution. Additionally, the variability of serrated adenoma detection among endoscopists will be evaluated and the characteristics of serrated adenomas will be de...
What is the current status of trial NCT03442270?
This trial is currently completed. The enrollment target is 276 participants. The study started on 2018-03-20. Estimated completion is 2018-11-07.
What conditions does trial NCT03442270 study?
This clinical trial studies the following conditions: Healthy Patients Undergoing Screening Colonoscopy.
What interventions are being tested in trial NCT03442270?
The interventions under investigation include: No Intervention (OTHER).
Who is sponsoring clinical trial NCT03442270?
This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03442270 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.